Last week I had the pleasure of spending a few days in Boston attending two separate life science events, Device Talks and McDermott Will & Emery’s Life Sciences Dealmaking Symposium. Although I love spending time in Boston, which is booming, I wish these events had been another week as I was not at home for … Continue reading Device Talks Boston – A Recap
One of the most common questions I get asked comes from Pre-Clinical Life Science companies is why do I need insurance? I agree that pre-clinical life science companies have about as little risk as a company can have. Why they need insurance really comes down to contracts, investors and statutory regulations. If the company enters … Continue reading Common Question Friday – Why Do Pre-Clinical Companies Need Insurance?
Welcome to a new work week, the final couple of days of July. Here is what I'm reading this morning: The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs (Benzinga) Would AbbVie’s top execs really pull the trigger on a $30B M&A deal? Why, yes, actually (Endpoints) 7 medtech stories we missed this … Continue reading Monday Morning Healthcare News